Xiangqian Zheng
7PUBLICATIONS
23CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 03, 2025
Persistent pre-exhausted CD8+ T cells shape the tumor immune microenvironment in anaplastic thyroid cancer.Xianhui Ruan, Mei Tao, Yuanxing Dong
|Aug 18, 2023
Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase II Trial.Yihebali Chi, Xiangqian Zheng, Yuan Zhang
|Jun 27, 2022
TET3 Mediates 5hmC Level and Promotes Tumorigenesis by Activating AMPK Pathway in Papillary Thyroid Cancer.Jiadong Chi, Wei Zhang, Yigong Li
|Dec 07, 2021
Reduced MHC class II expression in medullary thyroid cancer identifies patients with poor prognosis.Xianhui Ruan, Jiaoyu Yi, Linfei Hu
|Jul 30, 2021
A Randomized, Phase III Study of Lenvatinib in Chinese Patients with Radioiodine-Refractory Differentiated Thyroid Cancer.Xiangqian Zheng, Zhengang Xu, Qinghai Ji
|Feb 25, 2021
Oncoprotein HBXIP promotes tumorigenesis through MAPK/ERK pathway activation in non-small cell lung cancer.Jun Zhang, Bei Sun, Xianhui Ruan
Pageof 2
